EX-23.2 3 tm2530718d1_ex23-2.htm EXHIBIT 23.2

 

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 of Fennec Pharmaceuticals Inc. (the “Company”) of our report dated March 26, 2025, relating to the consolidated financial statements as of December 31, 2024 and 2023, and for each of the years then ended, which appears in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

 

  /s/ Haskell & White LLP
   
  HASKELL & WHITE LLP

 

Irvine, California

 

November 18, 2025